- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT00702949
Pregabalin in Treating Women With Hot Flashes
A Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes
RATIONALE: Pregabalin may help relieve hot flashes in women with a history of breast cancer or those who have no history and do not wish to take estrogen therapy for fear of increased risk of breast cancer. It is not yet known what dose of pregabalin may be more effective in treating hot flashes.
PURPOSE: This is a randomized phase III trial to determine the efficacy of two doses of pregabalin, in comparison to placebo, in the prevention of hot flashes.
연구 개요
상세 설명
OBJECTIVES:
- To evaluate the efficacy of 150 mg of pregabalin versus placebo on hot flash scores in women with a history of breast cancer or women who do not wish to take estrogen therapy for fear of increased risk of breast cancer.
- To evaluate the side effect profile of different doses of pregabalin in these patients.
- To evaluate the effect of 150 mg of pregabalin versus placebo on the secondary outcome of interference of activities from hot flashes in these patients.
- To evaluate the efficacy and side effect profile of 75 mg of pregabalin versus placebo in these patients.
OUTLINE: Patients are stratified according to age (18-49 years vs ≥ 50 years); selective estrogen-receptor modulator (i.e., tamoxifen or raloxifene) or aromatase inhibitor use (yes vs no); duration of hot flashes (< 9 months vs ≥ 9 months); and frequency of hot flashes per 24-hour period (4-9 vs ≥ 10). Patients are randomized to 1 of 3 treatment arms.
- Arm I: Patients receive 75 mg of oral pregabalin twice daily for 6 weeks.
- Arm II: Patients receive 150 mg of oral pregabalin twice daily for 6 weeks.
- Arm III: Patients receive oral placebo twice daily for 6 weeks. Treatment in all arms continues in the absence of unacceptable toxicity.
Patients complete Hot Flash Diaries at baseline and once daily during treatment and the Symptom Experience Diary at baseline and once weekly during treatment. Patients also complete the Profile of Mood States and the Hot Flash Related Daily Interference Scale questionnaires at baseline and after completion of study treatment.
연구 유형
등록 (실제)
단계
- 3단계
연락처 및 위치
연구 장소
-
-
Arizona
-
Scottsdale, Arizona, 미국, 85259-5499
- Mayo Clinic Scottsdale
-
-
Colorado
-
Aurora, Colorado, 미국, 80012
- Aurora Presbyterian Hospital
-
Boulder, Colorado, 미국, 80301-9019
- Boulder Community Hospital
-
Colorado Springs, Colorado, 미국, 80933
- Penrose Cancer Center at Penrose Hospital
-
Denver, Colorado, 미국, 80210
- Porter Adventist Hospital
-
Denver, Colorado, 미국, 80220
- Rose Medical Center
-
Denver, Colorado, 미국, 80218
- Presbyterian - St. Luke's Medical Center
-
Denver, Colorado, 미국, 80204
- St. Anthony Central Hospital
-
Denver, Colorado, 미국, 80218
- St. Joseph Hospital
-
Denver, Colorado, 미국, 80224-2522
- CCOP - Colorado Cancer Research Program
-
Englewood, Colorado, 미국, 80110
- Swedish Medical Center
-
Grand Junction, Colorado, 미국, 81502
- St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
-
Greeley, Colorado, 미국, 80631
- North Colorado Medical Center
-
Lone Tree, Colorado, 미국, 80124
- Sky Ridge Medical Center
-
Longmont, Colorado, 미국, 80502
- Hope Cancer Care Center at Longmont United Hospital
-
Loveland, Colorado, 미국, 80539
- McKee Medical Center
-
Pueblo, Colorado, 미국, 81004
- St. Mary - Corwin Regional Medical Center
-
Thornton, Colorado, 미국, 80229
- North Suburban Medical Center
-
Wheat Ridge, Colorado, 미국, 80033
- Exempla Lutheran Medical Center
-
-
Florida
-
Jacksonville, Florida, 미국, 32224
- Mayo Clinic - Jacksonville
-
-
Illinois
-
Aurora, Illinois, 미국, 60504
- Rush-Copley Cancer Care Center
-
Bloomington, Illinois, 미국, 61701
- St. Joseph Medical Center
-
Canton, Illinois, 미국, 61520
- Graham Hospital
-
Carthage, Illinois, 미국, 62321
- Memorial Hospital
-
Eureka, Illinois, 미국, 61530
- Eureka Community Hospital
-
Galesburg, Illinois, 미국, 61401
- Galesburg Cottage Hospital
-
Galesburg, Illinois, 미국, 61401
- Galesburg Clinic, PC
-
Havana, Illinois, 미국, 62644
- Mason District Hospital
-
Hopedale, Illinois, 미국, 61747
- Hopedale Medical Complex
-
Joliet, Illinois, 미국, 60435
- Joliet Oncology-Hematology Associates, Limited - West
-
Macomb, Illinois, 미국, 61455
- Mcdonough District Hospital
-
Normal, Illinois, 미국, 61761
- Bromenn Regional Medical Center
-
Normal, Illinois, 미국, 61761
- Community Cancer Center
-
Ottawa, Illinois, 미국, 61350
- Community Hospital of Ottawa
-
Ottawa, Illinois, 미국, 61350
- Oncology Hematology Associates of Central Illinois, PC - Ottawa
-
Pekin, Illinois, 미국, 61554
- Cancer Treatment Center at Pekin Hospital
-
Peoria, Illinois, 미국, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, 미국, 61614
- Proctor Hospital
-
Peoria, Illinois, 미국, 61637
- OSF St. Francis Medical Center
-
Peoria, Illinois, 미국, 61615
- CCOP - Illinois Oncology Research Association
-
Peoria, Illinois, 미국, 61615
- Oncology Hematology Associates of Central Illinois, PC - Peoria
-
Peru, Illinois, 미국, 61354
- Illinois Valley Community Hospital
-
Princeton, Illinois, 미국, 61356
- Perry Memorial Hospital
-
Spring Valley, Illinois, 미국, 61362
- St. Margaret's Hospital
-
Urbana, Illinois, 미국, 61801
- Carle Cancer Center at Carle Foundation Hospital
-
Urbana, Illinois, 미국, 61801
- CCOP - Carle Cancer Center
-
-
Indiana
-
Elkhart, Indiana, 미국, 46515
- Elkhart General Hospital
-
Kokomo, Indiana, 미국, 46904
- Howard Community Hospital
-
La Porte, Indiana, 미국, 46350
- Center for Cancer Therapy at LaPorte Hospital and Health Services
-
Michigan City, Indiana, 미국, 46360
- Saint Anthony Memorial Health Centers
-
South Bend, Indiana, 미국, 46601
- Memorial Hospital of South Bend
-
South Bend, Indiana, 미국, 46601
- CCOP - Northern Indiana CR Consortium
-
South Bend, Indiana, 미국, 46617
- Saint Joseph Regional Medical Center
-
South Bend, Indiana, 미국, 46617
- South Bend Clinic
-
-
Iowa
-
Cedar Rapids, Iowa, 미국, 52403
- Cedar Rapids Oncology Associates
-
Des Moines, Iowa, 미국, 50309
- CCOP - Iowa Oncology Research Association
-
Des Moines, Iowa, 미국, 50309
- John Stoddard Cancer Center at Iowa Methodist Medical Center
-
Des Moines, Iowa, 미국, 50309
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
-
Des Moines, Iowa, 미국, 50314
- Medical Oncology and Hematology Associates at Mercy Cancer Center
-
Des Moines, Iowa, 미국, 50314
- Mercy Cancer Center at Mercy Medical Center - Des Moines
-
Des Moines, Iowa, 미국, 50316
- John Stoddard Cancer Center at Iowa Lutheran Hospital
-
Des Moines, Iowa, 미국, 50307
- Mercy Capitol Hospital
-
Ottumwa, Iowa, 미국, 52501
- McCreery Cancer Center at Ottumwa Regional
-
Sioux City, Iowa, 미국, 51101
- Siouxland Hematology-Oncology Associates, LLP
-
Sioux City, Iowa, 미국, 51104
- St. Luke's Regional Medical Center
-
Sioux City, Iowa, 미국, 51104
- Mercy Medical Center - Sioux City
-
-
Kansas
-
Chanute, Kansas, 미국, 66720
- Cancer Center of Kansas, PA - Chanute
-
Dodge City, Kansas, 미국, 67801
- Cancer Center of Kansas, PA - Dodge City
-
El Dorado, Kansas, 미국, 67042
- Cancer Center of Kansas, PA - El Dorado
-
Independence, Kansas, 미국, 67301
- Cancer Center of Kansas-Independence
-
Kingman, Kansas, 미국, 67068
- Cancer Center of Kansas, PA - Kingman
-
Liberal, Kansas, 미국, 67901
- Southwest Medical Center
-
Newton, Kansas, 미국, 67114
- Cancer Center of Kansas, PA - Newton
-
Parsons, Kansas, 미국, 67357
- Cancer Center of Kansas, PA - Parsons
-
Pratt, Kansas, 미국, 67124
- Cancer Center of Kansas, PA - Pratt
-
Salina, Kansas, 미국, 67042
- Cancer Center of Kansas, PA - Salina
-
Wellington, Kansas, 미국, 67152
- Cancer Center of Kansas, PA - Wellington
-
Wichita, Kansas, 미국, 67208
- Cancer Center of Kansas, PA - Medical Arts Tower
-
Wichita, Kansas, 미국, 67214
- Cancer Center of Kansas, PA - Wichita
-
Wichita, Kansas, 미국, 67214
- CCOP - Wichita
-
Wichita, Kansas, 미국, 67214
- Via Christi Cancer Center at Via Christi Regional Medical Center
-
Wichita, Kansas, 미국, 67208
- Associates in Womens Health, PA - North Review
-
Winfield, Kansas, 미국, 67156
- Cancer Center of Kansas, PA - Winfield
-
-
Michigan
-
Adrian, Michigan, 미국, 49221
- Hickman Cancer Center at Bixby Medical Center
-
Ann Arbor, Michigan, 미국, 48106-0995
- Saint Joseph Mercy Cancer Center
-
Ann Arbor, Michigan, 미국, 48106
- CCOP - Michigan Cancer Research Consortium
-
Dearborn, Michigan, 미국, 48123-2500
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
-
Escanaba, Michigan, 미국, 49431
- Green Bay Oncology, Limited - Escanaba
-
Flint, Michigan, 미국, 48503
- Hurley Medical Center
-
Flint, Michigan, 미국, 48503
- Genesys Hurley Cancer Institute
-
Grosse Pointe Woods, Michigan, 미국, 48236
- Van Elslander Cancer Center at St. John Hospital and Medical Center
-
Iron Mountain, Michigan, 미국, 49801
- Dickinson County Healthcare System
-
Jackson, Michigan, 미국, 49201
- Foote Memorial Hospital
-
Lambertville, Michigan, 미국, 48144
- Haematology-Oncology Associates of Ohio and Michigan, PC
-
Lansing, Michigan, 미국, 48912-1811
- Sparrow Regional Cancer Center
-
Livonia, Michigan, 미국, 48154
- St. Mary Mercy Hospital
-
Monroe, Michigan, 미국, 48162
- Community Cancer Center of Monroe
-
Monroe, Michigan, 미국, 48162
- Mercy Memorial Hospital - Monroe
-
Pontiac, Michigan, 미국, 48341-2985
- St. Joseph Mercy Oakland
-
Port Huron, Michigan, 미국, 48060
- Mercy Regional Cancer Center at Mercy Hospital
-
Saginaw, Michigan, 미국, 48601
- Seton Cancer Institute at Saint Mary's - Saginaw
-
St. Joseph, Michigan, 미국, 49085
- Lakeland Regional Cancer Care Center - St. Joseph
-
Warren, Michigan, 미국, 48093
- St. John Macomb Hospital
-
-
Minnesota
-
Bemidji, Minnesota, 미국, 56601
- MeritCare Bemidji
-
Burnsville, Minnesota, 미국, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, 미국, 55433
- Mercy and Unity Cancer Center at Mercy Hospital
-
Edina, Minnesota, 미국, 55435
- Fairview Southdale Hospital
-
Fergus Falls, Minnesota, 미국, 56537
-
Fridley, Minnesota, 미국, 55432
- Mercy and Unity Cancer Center at Unity Hospital
-
Mankato, Minnesota, 미국, 56002
- Immanuel St. Joseph's
-
Maplewood, Minnesota, 미국, 55109
- Minnesota Oncology Hematology, PA - Maplewood
-
Minneapolis, Minnesota, 미국, 55407
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
-
Robbinsdale, Minnesota, 미국, 55422-2900
- Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
-
Rochester, Minnesota, 미국, 55905
- Mayo Clinic Cancer Center
-
Saint Cloud, Minnesota, 미국, 56303
- CentraCare Clinic - River Campus
-
Saint Cloud, Minnesota, 미국, 56303
- Coborn Cancer Center
-
Saint Louis Park, Minnesota, 미국, 55416
- CCOP - Metro-Minnesota
-
Saint Louis Park, Minnesota, 미국, 55416
- Park Nicollet Cancer Center
-
Saint Paul, Minnesota, 미국, 55102
- United Hospital
-
Waconia, Minnesota, 미국, 55387
- Ridgeview Medical Center
-
Woodbury, Minnesota, 미국, 55125
- Minnesota Oncology Hematology, PA - Woodbury
-
-
Missouri
-
Saint Louis, Missouri, 미국, 63131
- Missouri Baptist Cancer Center
-
Saint Louis, Missouri, 미국, 63141
- Arch Medical Services, Incorporated at Center for Cancer Care and Research
-
-
Montana
-
Billings, Montana, 미국, 59101
- CCOP - Montana Cancer Consortium
-
Billings, Montana, 미국, 59101
- Hematology-Oncology Centers of the Northern Rockies - Billings
-
Billings, Montana, 미국, 59101
- Northern Rockies Radiation Oncology Center
-
Billings, Montana, 미국, 59101
- St. Vincent Healthcare Cancer Care Services
-
Billings, Montana, 미국, 59107-7000
- Billings Clinic - Downtown
-
Bozeman, Montana, 미국, 59715
- Bozeman Deaconess Cancer Center
-
Butte, Montana, 미국, 59701
- St. James Healthcare Cancer Care
-
Great Falls, Montana, 미국, 59405
- Great Falls Clinic - Main Facility
-
Great Falls, Montana, 미국, 59405
-
Havre, Montana, 미국, 59501
- Northern Montana Hospital
-
Helena, Montana, 미국, 59601
- St. Peter's Hospital
-
Kalispell, Montana, 미국, 59901
- Kalispell Regional Medical Center
-
Kalispell, Montana, 미국, 59901
- Glacier Oncology, PLLC
-
Kalispell, Montana, 미국, 59901
- Kalispell Medical Oncology at KRMC
-
Missoula, Montana, 미국, 59801
- Community Medical Center
-
Missoula, Montana, 미국, 59804
- Guardian Oncology and Center for Wellness
-
Missoula, Montana, 미국, 59807-7877
- Montana Cancer Specialists at Montana Cancer Center
-
Missoula, Montana, 미국, 59807
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
-
-
Nebraska
-
Lincoln, Nebraska, 미국, 68510
- Cancer Resource Center - Lincoln
-
Omaha, Nebraska, 미국, 68106
- CCOP - Missouri Valley Cancer Consortium
-
Omaha, Nebraska, 미국, 68131-2197
- Creighton University Medical Center
-
-
North Dakota
-
Bismarck, North Dakota, 미국, 58501
- Bismarck Cancer Center
-
Bismarck, North Dakota, 미국, 58501
- Medcenter One Hospital Cancer Care Center
-
Bismarck, North Dakota, 미국, 58501
- Mid Dakota Clinic, PC
-
Bismarck, North Dakota, 미국, 58502
- St. Alexius Medical Center Cancer Center
-
Fargo, North Dakota, 미국, 58122
- CCOP - MeritCare Hospital
-
Fargo, North Dakota, 미국, 58122
- MeritCare Broadway
-
-
Ohio
-
Bellefontaine, Ohio, 미국, 43311
- Mary Rutan Hospital
-
Bowling Green, Ohio, 미국, 43402
- Wood County Oncology Center
-
Chillicothe, Ohio, 미국, 45601
- Adena Regional Medical Center
-
Columbus, Ohio, 미국, 43214-3998
- Riverside Methodist Hospital Cancer Care
-
Columbus, Ohio, 미국, 43222
- Mount Carmel Health - West Hospital
-
Columbus, Ohio, 미국, 43215
- CCOP - Columbus
-
Columbus, Ohio, 미국, 43215
- Grant Medical Center Cancer Care
-
Columbus, Ohio, 미국, 43228
- Doctors Hospital at Ohio Health
-
Delaware, Ohio, 미국, 43015
- Grady Memorial Hospital
-
Lancaster, Ohio, 미국, 43130
- Fairfield Medical Center
-
Lima, Ohio, 미국, 45804
- Lima Memorial Hospital
-
Marietta, Ohio, 미국, 45750
- Strecker Cancer Center at Marietta Memorial Hospital
-
Maumee, Ohio, 미국, 43537
- Northwest Ohio Oncology Center
-
Maumee, Ohio, 미국, 43537
- St. Luke's Hospital
-
Newark, Ohio, 미국, 43055
- Licking Memorial Cancer Care Program at Licking Memorial Hospital
-
Oregon, Ohio, 미국, 43616
- St. Charles Mercy Hospital
-
Oregon, Ohio, 미국, 43616
- Toledo Clinic - Oregon
-
Sandusky, Ohio, 미국, 44870
- North Coast Cancer Care, Incorporated
-
Springfield, Ohio, 미국, 45505
- Community Hospital of Springfield and Clark County
-
Springfield, Ohio, 미국, 45504
- Mercy Medical Center
-
Sylvania, Ohio, 미국, 43560
- Flower Hospital Cancer Center
-
Tiffin, Ohio, 미국, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, 미국, 43608
- St. Vincent Mercy Medical Center
-
Toledo, Ohio, 미국, 43606
- Toledo Hospital
-
Toledo, Ohio, 미국, 43614
- Medical University of Ohio Cancer Center
-
Toledo, Ohio, 미국, 43617
- CCOP - Toledo Community Hospital
-
Toledo, Ohio, 미국, 43623
- Toledo Clinic, Incorporated - Main Clinic
-
Wauseon, Ohio, 미국, 43567
- Fulton County Health Center
-
Westerville, Ohio, 미국, 43081
- Mount Carmel St. Ann's Cancer Center
-
Zanesville, Ohio, 미국, 43701
- Genesis - Good Samaritan Hospital
-
-
Oregon
-
Gresham, Oregon, 미국, 97030
- Legacy Mount Hood Medical Center
-
Milwaukie, Oregon, 미국, 97222
- Providence Milwaukie Hospital
-
Portland, Oregon, 미국, 97216
- Adventist Medical Center
-
Portland, Oregon, 미국, 97210
- Legacy Good Samaritan Hospital & Comprehensive Cancer Center
-
Portland, Oregon, 미국, 97213-2967
- Providence Cancer Center at Providence Portland Medical Center
-
Portland, Oregon, 미국, 97225
- CCOP - Columbia River Oncology Program
-
Portland, Oregon, 미국, 97225
- Providence St. Vincent Medical Center
-
Portland, Oregon, 미국, 97227
- Legacy Emanuel Hospital and Health Center and Children's Hospital
-
Tualatin, Oregon, 미국, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Danville, Pennsylvania, 미국, 17822-0001
- Geisinger Cancer Institute at Geisinger Health
-
Hazleton, Pennsylvania, 미국, 18201
- Geisinger Hazleton Cancer Center
-
State College, Pennsylvania, 미국, 16801
- Geisinger Medical Group - Scenery Park
-
Wilkes-Barre, Pennsylvania, 미국, 18711
- Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
-
Wilkes-Barre, Pennsylvania, 미국, 18765
- Mercy Hospital at Wilkes-Barre
-
-
South Dakota
-
Rapid City, South Dakota, 미국, 57701
- Rapid City Regional Hospital
-
Sioux Falls, South Dakota, 미국, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, 미국, 57105
- Medical X-Ray Center, PC
-
Sioux Falls, South Dakota, 미국, 57117-5039
- Sanford Cancer Center at Sanford USD Medical Center
-
-
Virginia
-
Fredericksburg, Virginia, 미국, 22401
- Fredericksburg Oncology, Incorporated
-
-
Washington
-
Vancouver, Washington, 미국, 98668
- Southwest Washington Medical Center Cancer Center
-
-
Wisconsin
-
Fond du Lac, Wisconsin, 미국, 54935
- Central Wisconsin Cancer Program at Agnesian HealthCare
-
Green Bay, Wisconsin, 미국, 54307-3508
- St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, 미국, 54301-3526
- Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, 미국, 54303
- Green Bay Oncology, Limited at St. Mary's Hospital
-
Green Bay, Wisconsin, 미국, 54303
- St. Mary's Hospital Medical Center - Green Bay
-
Marinette, Wisconsin, 미국, 54143
- Bay Area Cancer Care Center at Bay Area Medical Center
-
Oconto Falls, Wisconsin, 미국, 54154
- Green Bay Oncology, Limited - Oconto Falls
-
Sturgeon Bay, Wisconsin, 미국, 54235
- Green Bay Oncology, Limited - Sturgeon Bay
-
-
Wyoming
-
Sheridan, Wyoming, 미국, 82801
- Welch Cancer Center at Sheridan Memorial Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
DISEASE CHARACTERISTICS:
Meeting 1 of the following criteria:
- History of breast cancer (currently without malignant disease)
- No history of breast cancer, but patient wishes to avoid estrogen due to a perceived increased risk of breast cancer
- Bothersome hot flashes (defined by their occurrence ≥ 28 times per week and of sufficient severity to make the patient desire therapeutic intervention)
- Presence of hot flashes for ≥ 1 month prior to study entry
PATIENT CHARACTERISTICS:
- Eastern Cooperative Oncology Group (ECOG) performance status 0-1
- Life expectancy ≥ 6 months
- Able to complete questionnaire(s) by themselves or with assistance
- Women of childbearing potential not eligible (per the judgment of the attending clinician)
- Serum creatinine ≤ 1.5 times upper limit of normal
PRIOR CONCURRENT THERAPY:
- No prior gabapentin or pregabalin
More than 4 weeks since prior and no concurrent antineoplastic chemotherapy, androgens, estrogens, or progestational agents
- Vaginal estrogen is allowed if used for the past month and not planned to be discontinued
- Concurrent adjuvant targeted therapy (i.e., lapatinib, trastuzumab [Herceptin®]) allowed in patients with no evidence of disease
- Concurrent tamoxifen, raloxifene, or aromatase inhibitors on a constant dose for at least 4 weeks allowed provided the medication will not be stopped during the study period
No concurrent or planned use of other agents for hot flashes except for any of the following:
- Stable dose of vitamin E is allowed as long as agent was started > 30 days prior to study initiation and is to be continued throughout the study period
- Soy is allowed, if it is planned to be continued at the same dose during the study period
- Stable dose of antidepressants is allowed as long as it was started > 30 days prior to study initiation and is to be continued at a stable dose throughout the study period
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Pregabalin75
Patients receive 75 mg of oral pregabalin twice daily for 6 weeks.
|
Given orally
|
실험적: Pregabalin150
Patients receive 150 mg of oral pregabalin twice daily for 6 weeks.
|
Given orally
|
위약 비교기: Placebo
Patients receive oral placebo twice daily for 6 weeks.
|
구두로 주어진
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Numerical Change From Baseline in Hot Flash Score at Treatment Week 6 (Positive Numbers to Represent Increases and Negative Numbers to Represent Decreases).
기간: Baseline, after week 6 of treatment
|
Hot flash activity will be analyzed in a number of ways.
For the primary analysis, the numerical change-from-baseline to hot flash score after week 6 of treatment will be compared between the highest dose treatment arm and the placebo arm.
A hot flash score is computed for each patient by assigning points (1=mild, 2=moderate, 3=severe, 4=very severe) to each hot flash based on patient-reported severity, adding the points for each day, and averaging across each week of the study.
Abbreviations for the analysis population description: Eligible patients (EPs).
Evaluable for primary (EFP).
Off-study for adverse event (AE).
Do not have 6 weeks of data (NODATA).
|
Baseline, after week 6 of treatment
|
Percent Change From Baseline in Hot Flash Score at Treatment Week 6 (Positive Numbers to Represent Increases and Negative Numbers to Represent Decreases).
기간: Baseline, after week 6 of treatment
|
Hot flash activity will be analyzed in a number of ways.
For the primary analysis, the percent change-from-baseline to hot flash score after week 6 of treatment will be compared between the highest dose treatment arm and the placebo arm.
A hot flash score is computed for each patient by assigning points (1=mild, 2=moderate, 3=severe, 4=very severe) to each hot flash based on patient-reported severity, adding the points for each day, and averaging across each week of the study.
Abbreviations for the analysis population description: Eligible patients (EPs).
Evaluable for primary (EFP).
Off-study for adverse event (AE).
Do not have 6 weeks of data (NODATA).
|
Baseline, after week 6 of treatment
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Numerical Change From Baseline in Hot Flash Frequency at Treatment Week 6 (Positive Numbers to Represent Increases and Negative Numbers to Represent Decreases).
기간: Baseline, after week 6 of treatment
|
The analysis of daily average hot flash frequency will follow as specified for the primary analysis.
Abbreviations for the analysis population description: Eligible patients (EPs).
Evaluable for primary (EFP).
Off-study for adverse event (AE).
Do not have 6 weeks of data (NODATA).
|
Baseline, after week 6 of treatment
|
Percent Change From Baseline in Hot Flash Frequency at Treatment Week 6 (Positive Numbers to Represent Increases and Negative Numbers to Represent Decreases).
기간: Baseline, after week 6 of treatment
|
The analysis of daily average hot flash frequency will follow as specified for the primary analysis.
Abbreviations for the analysis population description: Eligible patients (EPs).
Evaluable for primary (EFP).
Off-study for adverse event (AE).
Do not have 6 weeks of data (NODATA).
|
Baseline, after week 6 of treatment
|
Comparison of 75 mg of Pregabalin vs Placebo, Numerical Change From Baseline in Hot Flash Score at Treatment Week 6 (Positive Numbers to Represent Increases and Negative Numbers to Represent Decreases).
기간: Baseline, after week 6 of treatment
|
Hot flash activity will be analyzed in a number of ways.
For the this analysis, the numerical change-from-baseline to hot flash score after week 6 of treatment will be compared between the lower dose treatment arm and the placebo arm.
A hot flash score is computed for each patient by assigning points (1=mild, 2=moderate, 3=severe, 4=very severe) to each hot flash based on patient-reported severity, adding the points for each day, and averaging across each week of the study.
Abbreviations for the analysis population description: Eligible patients (EPs).
Evaluable for primary (EFP).
Off-study for adverse event (AE).
Do not have 6 weeks of data (NODATA).
|
Baseline, after week 6 of treatment
|
Comparison of 75 mg of Pregabalin vs Placebo. Percent Change From Baseline in Hot Flash Score at Treatment Week 6 (Positive Numbers to Represent Increases and Negative Numbers to Represent Decreases).
기간: Baseline, after week 6 of treatment
|
Hot flash activity will be analyzed in a number of ways.
For the this analysis, the percent change-from-baseline to hot flash score after week 6 of treatment will be compared between the lower dose treatment arm and the placebo arm.
A hot flash score is computed for each patient by assigning points (1=mild, 2=moderate, 3=severe, 4=very severe) to each hot flash based on patient-reported severity, adding the points for each day, and averaging across each week of the study.
Abbreviations for the analysis population description: Eligible patients (EPs).
Evaluable for primary (EFP).
Off-study for adverse event (AE).
Do not have 6 weeks of data (NODATA).
|
Baseline, after week 6 of treatment
|
Toxicity Data for the Individual Study Arms From the Symptom Experience Diary .
기간: Baseline, 6 weeks during treatment.
|
A descriptive report of the toxicities experienced by participants will be measured with a Symptom Experience Diary.
Participants will complete this questionnaire weekly.
This patient diary contains several questions related to potential side effects and side benefits of pregabalin measured on a numeric analogue scale (based on 0-10 scale with 10 being worst toxicity, providing numbers representing the worst median changes from baseline minus Maximum (Week 1-6) Symptom Experience Diary Distributions).
|
Baseline, 6 weeks during treatment.
|
Mood and Hot Flash-related Daily Interference on Activities After 6 Weeks of Treatment
기간: Baseline, after week 6 of treatment.
|
Endpoints for this analysis will be median change from baseline to after week 6 of treatment.
Hot Flash Related Daily Interference Scale is used to evaluate the specific impact of the study treatment on the effect hot flashes have on various life activities such as work, social, leisure and relationships.
Responses to the questionnaire are recorded on a 0 to 10 scale.
Lower scores are better.
|
Baseline, after week 6 of treatment.
|
공동 작업자 및 조사자
수사관
- 연구 의자: Charles Loprinzi, MD, Mayo Clinic
간행물 및 유용한 링크
일반 간행물
- Loprinzi CL, Qin R, Stella PJ, et al.: Pregabalin for hot flashes in women: NCCTG trial N07C1. [Abstract] J Clin Oncol 27 (Suppl 15): A-9513, 2009.
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- NCCTG-N07C1
- NCI-2012-02716 (레지스트리 식별자: CTRP (Clinical Trials Reporting System))
- CDR0000598191 (레지스트리 식별자: PDQ (Physician Data Query))
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
유방암에 대한 임상 시험
-
Georgetown UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.; Susan G. Komen Breast Cancer...완전한
-
University of UtahNational Cancer Institute (NCI)모병피로 | 좌식 생활 | 전이성 전립선암 | IV기 전립선암 AJCC(American Joint Committee on Cancer) v8 | IVA기 전립선암 AJCC(American Joint Committee on Cancer) v8 | IVB기 전립선암 AJCC(American Joint Committee on Cancer) v8미국
-
Jonsson Comprehensive Cancer Center아직 모집하지 않음전립선암 | IVB기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Rashmi Verma, MDNational Cancer Institute (NCI)모병거세저항성 전립선암 | 전이성 전립선 선암종 | IVB기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer Center빼는전립선 선암종 | 2기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer CenterMiraDX모집하지 않고 적극적으로전립선 선암종 | 2기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer Center종료됨거세저항성 전립선암 | 전이성 전립선암 | IVA기 전립선암 AJCC v8 | IVB기 전립선암 AJCC v8 | IV기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.종료됨2기 전립선암 AJCC v8 | IIIA기 전립선암 AJCC v8 | IIIB기 전립선암 AJCC v8 | IIC기 전립선암 AJCC v8 | 3기 전립선암 AJCC v8 | IIIC기 전립선암 AJCC v8 | IIA기 전립선암 AJCC v8 | IIB기 전립선암 AJCC v8 | 1기 전립선암 American Joint Committee on Cancer(AJCC) v8미국
-
Assiut University아직 모집하지 않음South Egypt Cancer Institute(SECI)에서 소아 악성종양 환자에 대한 KDIGO 기준을 사용하여 AKI의 누적 발병률을 확인하기 위해
위약에 대한 임상 시험
-
AJU Pharm Co., Ltd.OM Pharma SA모병
-
University Hospital, Strasbourg, France모집하지 않고 적극적으로